Politics

Politics By Lev Facher

Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people

Politics By Lev Facher

Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate

Politics By Lev Facher

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

Politics By Lev Facher

Trump taps Pence to lead U.S. coronavirus response

Politics By Lev Facher

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalot By Ed Silverman

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

Politics By Lev Facher and Ed Silverman

VA declines broad coverage for new J&J depression drug touted by Trump

Pharma By Priyanka Dayal McCluskey — Boston Globe

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

Politics By Nicholas Florko

How do you improve Medicare? Maybe you watch Major League Baseball

The Pharmalot View By Ed Silverman

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

Politics By Rick Berke

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Politics By Nicholas Florko

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Heavyweights By Rick Berke

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

Biotech By Damian Garde, Rebecca Robbins, and Adam Feuerstein

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Pharmalot By Ed Silverman

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Pharmalot By Ed Silverman

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Politics By Robert Weisman — Boston Globe

Drug costs plague seniors, but legislative relief may be elusive

Politics By Lev Facher

3 state legislative battles to watch in 2019

Pharmalot By Ed Silverman

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

Donald Trump speaks prior to signing bills intended to lower prescription drug prices

Politics By Nicholas Florko

Trump will give speech on drug prices Thursday

Pharmalot By Ed Silverman

New U.S. trade deal with Canada and Mexico is criticized for provisions affecting drug prices

Pharmalot By Elizabeth Cooney

Pharmalittle: Markups on generics are growing; drug-pricing rhetoric heats up

Politics By Lev Facher

Is mistrust of ‘big pharma’ enough to help unseat a Democratic stalwart in Congress?

Politics By Lev Facher

NIH is investigating researchers who might have failed to disclose contributions from foreign governments

Opinions Plus By Elizabeth Cooney

Most Read

In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices

As medical professionals, my husband and I know the Nigerian travel ban is cruel. Now the pain is personal

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

Webinar: Is the new Congress ready to lower drug costs?

A new push aims to bring mental health and addiction into the 2020 campaign conversation

HHS hints at major changes to Medicare that could mean higher costs for patients

More doctors need to vote and get politically involved

These Republicans campaigned on a bold drug-pricing pledge. Since they won, they’ve gone silent

All Coverage

Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people

Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

Trump taps Pence to lead U.S. coronavirus response

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

VA declines broad coverage for new J&J depression drug touted by Trump

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

How do you improve Medicare? Maybe you watch Major League Baseball

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Drug costs plague seniors, but legislative relief may be elusive

3 state legislative battles to watch in 2019

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

Trump will give speech on drug prices Thursday

New U.S. trade deal with Canada and Mexico is criticized for provisions affecting drug prices

Pharmalittle: Markups on generics are growing; drug-pricing rhetoric heats up

Is mistrust of ‘big pharma’ enough to help unseat a Democratic stalwart in Congress?

NIH is investigating researchers who might have failed to disclose contributions from foreign governments

Public distrust is high, PBMs are the problem, but the future is bright: a survey of biopharma pros

Most Read

All Coverage